医学
微生态学
粪便细菌疗法
肠外营养
肠内给药
重症监护医学
移植
内科学
抗生素
艰难梭菌
生态学
微生物学
生物
出处
期刊:PubMed
日期:2020-07-10
卷期号:23 (Z1): 5-13
被引量:8
标识
DOI:10.3760/cma.j.cn.441530-20200420-00231
摘要
Fecal microbiota transplantation (FMT) is to transplant the functional bacteria in the feces of healthy people into the patients' intestines, rebuild the new balance of intestinal flora, and achieve the treatment goals of intestinal and extraintestinal diseases. In the past 10 years, FMT has made a breakthrough in the treatment of intestinal and extraintestinal diseases, which is highly expected to treat difficult diseases. However, due to the complexity of FMT methodology and the lack of a unified standard, there is a high heterogeneity in FMT efficacy among various researches, greatly affected its clinical application. Under the initiative of Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced Recovery after Surgery Branch of China International Health Care Promotion Exchange Association, China Microecological Treatment Innovation Alliance, and Microecology Committee of Shanghai Preventive Medicine Association, the first expert consensus on standardized methodology and clinical application of FMT was established in China, with a view to improving the efficacy of FMT, reducing the incidence of adverse reactions and promoting the clinical application of FMT.
科研通智能强力驱动
Strongly Powered by AbleSci AI